◀ Back to ERVK-6

ERVK-6 — GZMB

Text-mined interactions from Literome

Hirst et al., J Immunol 2003 : The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency
Barrie et al., J Immunol 2004 (Adenoviridae Infections...) : Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6
Bladergroen et al., Eur J Immunol 2005 (Mastocytosis) : The activity of granzyme B , a main effector molecule of cytotoxic T lymphocytes ( CTL ) and natural killer cells, is regulated by the human intracellular serpin proteinase inhibitor 9 (PI9)
Jiang et al., Endocrinology 2006 : Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells
Matsunami et al., Transpl Int 2007 : The activity of granzyme B , a main effector molecule of natural killer ( NK ) cells and cytotoxic T lymphocytes, is regulated by the intracellular serine proteinase inhibitor 9 (PI-9)